You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › July › 11
Medical
16 days ago
Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and diabetes counterpart Ozempic.
page 1 of 1